Evidence map›Paper›PMID 39786929›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Structural basis for TIR domain-mediated innate immune signaling by Toll-like receptor adaptors TRIF and TRAM.

Mohammad K Manik, Mengqi Pan, Le Xiao, Weixi Gu, Hyoyoung Kim, Sabrina Pospich, Andrew Hedger, Parimala R Vajjhala, Morris Y L Lee, Xiaoqi Qian and 7 more

Erratum issuedAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Mohammad K Manik *Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.ORCID 0000-0001-9510-2250
Mengqi Pan *School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, QLD 4072, Australia.
Le Xiao *Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.
Weixi Gu *School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, QLD 4072, Australia.
Hyoyoung Kim *School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, QLD 4072, Australia.
Sabrina PospichDepartment of Structural Biochemistry, Max Planck Institute of Molecular Physiology, Dortmund 44227, Germany.ORCID 0000-0002-5119-3039
Andrew HedgerSchool of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, QLD 4072, Australia.
Parimala R VajjhalaSchool of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, QLD 4072, Australia.
Morris Y L LeeSchool of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, QLD 4072, Australia.
Xiaoqi QianSchool of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, QLD 4072, Australia.
Michael J LandsbergSchool of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, QLD 4072, Australia.
Thomas VeInstitute for Biomedicine and Glycomics, Griffith University, Gold Coast, QLD 4215, Australia.
Jeffrey D NansonSchool of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, QLD 4072, Australia.ORCID 0000-0003-1306-1948
Stefan RaunserDepartment of Structural Biochemistry, Max Planck Institute of Molecular Physiology, Dortmund 44227, Germany.ORCID 0000-0001-9373-3016
Katryn J StaceySchool of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, QLD 4072, Australia.
Hao WuDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.ORCID 0000-0002-7281-8579
Bostjan KobeSchool of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, QLD 4072, Australia.ORCID 0000-0001-9413-9166

Funding

Structural & Functional Studies of TLR/IL-1R SignalingR37AI050872 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI WU, HAO · 2012 to 2021
$4.7M
Structural Studies of Protein Caspase InhibitorsR01AI050872 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI WU, HAO · 2002 to 2012
$3.6M
Cancer Research Institute (CRI) Irvington fellowshipDHAC | National Health and Medical Research Council (NHMRC) 1196590DHAC | National Health and Medical Research Council (NHMRC) 2025931HHS | National Institutes of Health (NIH) AI050872NIAID NIH HHS R01 AI050872NIAID NIH HHS R37 AI050872
6 · The paper itself

Abstract

Innate immunity relies on Toll-like receptors (TLRs) to detect pathogen-associated molecular patterns. The TIR (Toll/interleukin-1 receptor) domain-containing TLR adaptors TRIF (TIR domain-containing adaptor-inducing interferon-β) and TRAM (TRIF-related adaptor molecule) are essential for MyD88-independent TLR signaling. However, the structural basis of TRIF and TRAM TIR domain-based signaling remains unclear. Here, we present cryo-EM structures of filaments formed by TRIF and TRAM TIR domains at resolutions of 3.3 Å and 5.6 Å, respectively. Both structures reveal two-stranded parallel helical arrangements. Functional studies underscore the importance of intrastrand interactions, mediated by the BB-loop, and interstrand interactions in TLR4-mediated signaling. We also report the crystal structure of the monomeric TRAM TIR domain bearing the BB loop mutation C117H, which reveals conformational differences consistent with its inactivity. Our findings suggest a unified signaling mechanism by the TIR domains of the four signaling TLR adaptors MyD88, MAL, TRIF, and TRAM and reveal potential therapeutic targets for immunity-related disorders.

Indexed as

Adaptor Proteins, Vesicular TransportImmunity, InnateSignal TransductionAdaptor Proteins, Signal TransducingCryoelectron MicroscopyCrystallography, X-RayHEK293 CellsHumansModels, MolecularMyeloid Differentiation Factor 88Protein DomainsReceptors, Interleukin-1Toll-Like Receptor 4Toll-Like ReceptorsAdaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportMyeloid Differentiation Factor 88Receptors, Interleukin-1TICAM1 protein, humanTICAM2 protein, humanTLR4 protein, humanToll-Like Receptor 4Toll-Like Receptorscryo-EMhelical reconstructionMyD88-independent TLR signalingTIR domain

Identifiers

PMID39786929
PMCPMC11745336

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.